Published in J Infect Dis on August 15, 2003
Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother (2004) 2.23
Distribution and characteristics of Escherichia coli clonal group A. Emerg Infect Dis (2005) 1.87
Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol (2006) 1.85
Genetic background of Escherichia coli and extended-spectrum beta-lactamase type. Emerg Infect Dis (2005) 1.81
Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun (2012) 1.74
Rapid and specific detection of Escherichia coli clonal group A by gene-specific PCR. J Clin Microbiol (2004) 1.65
Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother (2005) 1.49
Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother (2009) 1.49
Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob Agents Chemother (2005) 1.47
Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections. J Clin Microbiol (2003) 1.45
Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and Emphysematous pyelonephritis. J Clin Microbiol (2009) 1.44
Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol (2005) 1.36
Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother (2005) 1.29
Quinolone resistance in Escherichia coli from Accra, Ghana. BMC Microbiol (2011) 1.27
Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrob Agents Chemother (2005) 1.22
Virulence potential of Escherichia coli isolates from skin and soft tissue infections. J Clin Microbiol (2009) 1.20
Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates. J Clin Microbiol (2010) 1.17
Colonization with extraintestinal pathogenic Escherichia coli among nursing home residents and its relationship to fluoroquinolone resistance. Antimicrob Agents Chemother (2004) 1.13
Rapid and specific detection of the O15:K52:H1 clonal group of Escherichia coli by gene-specific PCR. J Clin Microbiol (2004) 1.08
Emergence and outbreaks of CTX-M beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital. J Clin Microbiol (2006) 1.07
Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns. J Clin Microbiol (2009) 1.05
Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis (2011) 1.03
Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children. Clin Infect Dis (2014) 1.02
Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model. Antimicrob Agents Chemother (2010) 0.99
Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype. Antimicrob Agents Chemother (2005) 0.94
Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women. J Clin Microbiol (2013) 0.94
The antibiotic susceptibility patterns of uropathogenic Escherichia coli, with special reference to the fluoroquinolones. J Clin Diagn Res (2013) 0.91
Sequence analysis of the Escherichia coli O15 antigen gene cluster and development of a PCR assay for rapid detection of intestinal and extraintestinal pathogenic E. coli O15 strains. J Clin Microbiol (2005) 0.90
Zoonotic potential of Escherichia coli isolates from retail chicken meat products and eggs. Appl Environ Microbiol (2014) 0.89
Detection of clonal group A Escherichia coli isolates from broiler chickens, broiler chicken meat, community-dwelling humans, and urinary tract infection (UTI) patients and their virulence in a mouse UTI model. Appl Environ Microbiol (2010) 0.88
Association between the presence of class 1 integrons, virulence genes, and phylogenetic groups of Escherichia coli isolates from river water. Microb Ecol (2012) 0.84
Virulence profiles, phylogenetic background, and antibiotic resistance of Escherichia coli isolated from turkeys with airsacculitis. ScientificWorldJournal (2014) 0.84
Fluoroquinolone-resistant Escherichia coli, Indonesia. Emerg Infect Dis (2005) 0.82
Phylogenetic groups of Escherichia coli strains from patients with urinary tract infection in Iran based on the new Clermont phylotyping method. Biomed Res Int (2015) 0.80
Assessing the diversity of the virulence potential of Escherichia coli isolated from bacteremia in São Paulo, Brazil. Braz J Med Biol Res (2013) 0.80
Phylogenetic Distribution of Virulence Genes Among ESBL-producing Uropathogenic Escherichia coli Isolated from Long-term Hospitalized Patients. J Clin Diagn Res (2015) 0.78
Virulence potential of Escherichia coli strains causing asymptomatic bacteriuria during pregnancy. J Clin Microbiol (2011) 0.78
Fluoroquinolone-resistant Haemophilus parasuis isolates exhibit more putative virulence factors than their susceptible counterparts. J Clin Microbiol (2013) 0.77
Virulence factors in Escherichia coli. J Clin Microbiol (2005) 0.77
Antimicrobial non-susceptibility of cervico-vaginal and rectal Escherichia coli isolates is associated with phylogeny and plasmid carriage. Eur J Clin Microbiol Infect Dis (2009) 0.77
Seasonal and genotypic changes in escherichia coli phylogenetic groups in the Yeongsan River basin of South Korea. PLoS One (2014) 0.76
Diverse and abundant multi-drug resistant E. coli in Matang mangrove estuaries, Malaysia. Front Microbiol (2015) 0.76
Infections caused by fluoroquinolone-resistant Escherichia coli following transrectal ultrasound-guided biopsy of the prostate. J Glob Antimicrob Resist (2014) 0.75
First report of the ceftazidimase CTX-M-19 in South America. New Microbes New Infect (2013) 0.75
Putative link between the virulence-associated fluA gene and fluoroquinolone resistance in uropathogenic Escherichia coli. J Clin Microbiol (2009) 0.75
Characterization of Escherichia coli Phylogenetic Groups Associated with Extraintestinal Infections in South Indian Population. Ann Med Health Sci Res (2015) 0.75
High Prevalence of Gut Microbiota Colonization with Broad-Spectrum Cephalosporin Resistant Enterobacteriaceae in a Tunisian Intensive Care Unit. Front Microbiol (2016) 0.75
Multidrug Resistant CTX-M-Producing Escherichia coli: A Growing Threat among HIV Patients in India. J Pathog (2016) 0.75
Evaluation of Escherichia coli isolates from healthy chickens to determine their potential risk to poultry and human health. PLoS One (2017) 0.75
Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci (2004) 9.73
Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis (2010) 4.98
Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother (2009) 3.79
Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis (2013) 2.85
Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother (2003) 2.51
Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis (2007) 2.34
Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint. Arthritis Rheum (2012) 2.28
Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. J Infect Dis (2006) 2.23
Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol (2012) 2.22
Antimicrobial-resistant and extraintestinal pathogenic Escherichia coli in retail foods. J Infect Dis (2005) 2.21
Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother (2012) 2.17
Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis (2012) 2.05
Complications of Foley catheters--is infection the greatest risk? J Urol (2012) 2.00
C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation (2005) 1.92
Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J Infect Dis (2006) 1.92
Distribution and characteristics of Escherichia coli clonal group A. Emerg Infect Dis (2005) 1.87
Molecular Analysis of Escherichia coli from retail meats (2002-2004) from the United States National Antimicrobial Resistance Monitoring System. Clin Infect Dis (2009) 1.86
Reduction of inappropriate urinary catheter use at a Veterans Affairs hospital through a multifaceted quality improvement project. Clin Infect Dis (2011) 1.79
Phylogenetic distribution of virulence-associated genes among Escherichia coli isolates associated with neonatal bacterial meningitis in the Netherlands. J Infect Dis (2002) 1.77
Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun (2012) 1.74
Quantifying the extent of femoral head involvement in osteonecrosis. J Bone Joint Surg Am (2003) 1.66
Rapid and specific detection of Escherichia coli clonal group A by gene-specific PCR. J Clin Microbiol (2004) 1.65
Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain. Pain (2011) 1.64
Analysis of nontypeable haemophilus influenzae phase-variable genes during experimental human nasopharyngeal colonization. J Infect Dis (2013) 1.64
Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. J Clin Microbiol (2008) 1.63
Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J Infect Dis (2004) 1.59
Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis (2004) 1.58
Association between Parkinson's disease and low bone density and falls in older men: the osteoporotic fractures in men study. J Am Geriatr Soc (2005) 1.58
Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis (2004) 1.56
Expansion rates and outcomes for the 3.0-cm to the 3.9-cm infrarenal abdominal aortic aneurysm. J Vasc Surg (2002) 1.55
Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain (2005) 1.52
An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat. Brain Res (2007) 1.49
Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol (2008) 1.49
Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother (2009) 1.49
Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections. J Clin Microbiol (2003) 1.45
Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands. J Infect Dis (2002) 1.44
First description of Klebsiella pneumoniae harboring CTX-M beta-lactamases (CTX-M-14 and CTX-M-3) in Taiwan. Antimicrob Agents Chemother (2002) 1.42
Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010. Antimicrob Agents Chemother (2013) 1.40
Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob Agents Chemother (2011) 1.36
Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol (2005) 1.36
Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia. J Infect Dis (2002) 1.36
Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med (2006) 1.35
Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat. Neurosci Lett (2006) 1.34
Association between ceftiofur use and isolation of Escherichia coli with reduced susceptibility to ceftriaxone from fecal samples of dairy cows. Am J Vet Res (2006) 1.30
A fracture pain model in the rat: adaptation of a closed femur fracture model to study skeletal pain. Anesthesiology (2008) 1.29
Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother (2005) 1.29
Escherichia coli colonization patterns among human household members and pets, with attention to acute urinary tract infection. J Infect Dis (2008) 1.26
Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan. Emerg Infect Dis (2002) 1.25
Failure to resurface the patella during total knee arthroplasty may result in more knee pain and secondary surgery. Clin Orthop Relat Res (2005) 1.24
Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection. Clin Infect Dis (2008) 1.24
Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain. J Neurosci (2010) 1.24
Evaluation of a quantitative magnetic resonance imaging system for whole body composition analysis in rodents. Obesity (Silver Spring) (2010) 1.22
Where the brain grows old: decline in anterior cingulate and medial prefrontal function with normal aging. Neuroimage (2007) 1.21
Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol (2005) 1.17
Virulence genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from humans, dogs, and cats. J Clin Microbiol (2007) 1.17
Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy women. Microbes Infect (2008) 1.16
Multiple-host sharing, long-term persistence, and virulence of Escherichia coli clones from human and animal household members. J Clin Microbiol (2008) 1.15
Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture. Pain (2007) 1.15
Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation (2005) 1.14
Identification of urovirulence traits in Escherichia coli by comparison of urinary and rectal E. coli isolates from dogs with urinary tract infection. J Clin Microbiol (2003) 1.14
Host-pathogen relationships among Escherichia coli isolates recovered from men with febrile urinary tract infection. Clin Infect Dis (2005) 1.13
Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA (2004) 1.11
Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol (2005) 1.11
Screening for cognitive impairment in an elderly veteran population: acceptability and results using different versions of the Mini-Cog. J Am Geriatr Soc (2011) 1.10
Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Circulation (2009) 1.10
High-frequency secondary mutations after suicide-driven allelic exchange mutagenesis in extraintestinal pathogenic Escherichia coli. J Bacteriol (2003) 1.09
Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009. Vaccine (2012) 1.09
Rapid and specific detection of the O15:K52:H1 clonal group of Escherichia coli by gene-specific PCR. J Clin Microbiol (2004) 1.08
Three-decade epidemiological analysis of Escherichia coli O15:K52:H1. J Clin Microbiol (2009) 1.07
Breast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibers. J Pain (2011) 1.06
Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur. J Bone Miner Res (2007) 1.05
Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain. Mol Pain (2010) 1.03
Global distribution and epidemiologic associations of Escherichia coli clonal group A, 1998-2007. Emerg Infect Dis (2011) 1.01
Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Arch Intern Med (2008) 1.01
Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol (2005) 1.01
Differences in site-specific fracture risk among older women with discordant results for osteoporosis at hip and spine: study of osteoporotic fractures. J Clin Densitom (2008) 1.00
Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and Coresistance phenotype among recent Escherichia coli isolates from U.S. veterans. Antimicrob Agents Chemother (2013) 1.00
A natural mineral supplement provides relief from knee osteoarthritis symptoms: a randomized controlled pilot trial. Nutr J (2008) 0.99
Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism. Neuroimage (2008) 0.99
Emergence of two Klebsiella pneumoniae isolates harboring plasmid-mediated CTX-M-15 beta-lactamase in Taiwan. Antimicrob Agents Chemother (2004) 0.99
Virulence factors predict Escherichia coli colonization patterns among human and animal household members. Ann Intern Med (2004) 0.99
A whey-protein supplement increases fat loss and spares lean muscle in obese subjects: a randomized human clinical study. Nutr Metab (Lond) (2008) 0.98
Impact of preoperative smoking status on postoperative complication rates and pulmonary function test results 1-year following pulmonary resection for non-small cell lung cancer. Lung Cancer (2008) 0.98
Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial. J Infect Dis (2012) 0.98
Preoperative pulmonary function and mortality after cardiac surgery. Am Heart J (2010) 0.97
Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer. Gastroenterology (2006) 0.96
Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections. Vaccine (2007) 0.96
Associations between multidrug resistance, plasmid content, and virulence potential among extraintestinal pathogenic and commensal Escherichia coli from humans and poultry. Foodborne Pathog Dis (2011) 0.96
A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: a randomised, placebo controlled pilot study. Nutr J (2009) 0.95